Video Case Studies
We’ve helped over 700 businesses to scale
Here are just some of their stories:
COMPANY: Blue Prism
INDUSTRY: Robotic Process Automation
OUR WORK: Resourcing, consultancy
CONTEXT: Blue Prism are the pioneers of Robotic Process Automation, an industry now worth billions worldwide.
CRSI was introduced to Blue Prism through one of the original key investors when they had just secured their first seed investment. Blue Prism is now a global business employing over 1000 people.
CRSI have introduced 100 people into key roles over the last few years.
COMPANY: CognAssist
INDUSTRY: Neurodiversity assessment software for Education
OUR WORK: Resourcing
CONTEXT: CognAssist are the creators of a new kind of cognitive mapping software that is able to identify neurodiversity among learners and provide personalised learning strategies.
CRSI was introduced to them through their investor and has helped with senior hires in the commercial and technical teams.
COMPANY: Collabco
INDUSTRY: Education and health connectivity software
OUR WORK: Consultancy, resourcing
CONTEXT: Collabco are the company behind ‘MyDay’ the collaborative student communication portal favoured by universities and colleges across the world.
CRSI was introduced to the business through their investor when the business had fewer than 10 employees. They have scaled rapidly and currently employ over 35 people. CRSI have been responsible for almost a third of their new hires, working with them to find people within sales, product management and software development.
COMPANY: e-Bate
INDUSTRY: Rebate management software (SaaS)
OUR WORK: Resourcing
CONTEXT: e-Bate is the UK’s first end-to-end rebate management software provider. They were spun out of a larger software house and secured VC funding to scale. CRSI was introduced to them through their investor and worked with them to find a non-executive chair.
COMPANY: MGB Biopharma
INDUSTRY: Life Sciences: Drug Discovery
OUR WORK: Resourcing
CONTEXT: MGB Biopharma are developing completely new class of anti-infective medicine which has antibacterial activity against susceptible and resistant bacteria.
CRSI was first introduced to MGB Biopharma through their network of angel investors and successfully found them their first Chief Business Officer.